Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1996
10/08/1996US5563169 Inhibitors of acylcoenzyme a:cholesterol transferase, for treatment and/or prevention of atherosclerosis
10/08/1996US5563157 Excitatory amino acid antagonists
10/08/1996US5563154 Tetrahydro-quinolinyl/isoquinolinyl-terminal alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
10/08/1996US5563151 Platelet activating factor receptor antagonists; antiinflammatory agents, analgesics
10/08/1996US5563145 Rapamycin 42-oximes and hydroxylamines
10/08/1996US5563144 Antiserotonins, their preparation and pharmaceutical compositions containing them
10/08/1996US5563139 Method of using 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of a glaucoma disorder
10/08/1996CA2051697C Heterocyclic amines having central nervous system activity
10/08/1996CA1338637C Process for the preparation of new derivative of dihydro-1,4 pyridine and pharmaceutical compositions containing them
10/04/1996CA2173305A1 Pyrazolidine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
10/03/1996WO1996030762A1 Insulin mimetic and enhancer assay
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030385A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996WO1996030358A1 Phenyl derivatives useful as endothelin receptor antagonists
10/03/1996WO1996030328A1 Terminal carboxy or tetrazole groups containing dialkyl ethers
10/03/1996WO1996030056A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/03/1996WO1996030048A1 Protein kinase c inhibitors
10/03/1996WO1996030042A2 Methods of treating inflammation and compositions therefor
10/03/1996WO1996030035A1 β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS
10/03/1996WO1996030028A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
10/03/1996WO1996030007A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
10/03/1996WO1996029999A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
10/03/1996WO1996029973A2 Compositions and methods for inhibiting thrombogenesis
10/03/1996WO1996024348A3 Use of carbazole compounds for the treatment of congestive heart failure
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2216878A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996CA2216806A1 Insulin mimetic and enhancer assay
10/03/1996CA2216278A1 Transdermally administrable medicament with ace inhibitors
10/03/1996CA2215833A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/03/1996CA2215720A1 .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
10/03/1996CA2214988A1 Method of treating inflammation and compositions therefor
10/02/1996EP0735038A1 Protein kinase C inhibitors
10/02/1996EP0734721A2 Method of incorporating drugs into a polymer component of stents
10/02/1996EP0734448A1 Gene therapy for restenosis using an adenoviral vector
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734381A1 Morpholine and thiomorpholine tachykinin receptor antagonists
10/02/1996EP0734376A1 Vitamin d amine and amide derivatives
10/02/1996EP0734373A1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
10/02/1996EP0734255A1 Novel potassium channel agonist produced from trichoderma virens
10/02/1996DE19512181A1 Transdermal applizierbares Arzneimittel mit ACE-Hemmern Transdermally administrable drug with ACE inhibitors
10/02/1996CN1132510A Hydroisoquinoline derivatives
10/02/1996CN1132475A Composion for releasing essence for nose
10/02/1996CN1132204A Novel heterocyclic amides
10/02/1996CN1132091A Prescription of bezoar oral liquid and its prodn. process
10/02/1996CN1132072A NK-1 receptor antagonists for treatment of neuronal injury and stroke
10/02/1996CN1132071A Medicinal compsn. for prevention and treatment of ischemic cerebral apoplexy
10/01/1996US5561234 1-(7-chloroquinolin-4-yl)pyrazole-3-carboxamide N-oxide derivatives, method of preparing them, and their pharmaceutical compositions
10/01/1996US5561163 Treating hearing loss with deprenyl
10/01/1996US5561150 Tricyclic pyrazole derivatives
10/01/1996US5561148 Oxazolidine derivative
10/01/1996US5561146 Modified guanidino and amidino thrombin inhibitors
10/01/1996US5561145 4-aryloxy- and 4-arylthiopiperidine derivatives
10/01/1996US5561144 (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
10/01/1996US5561134 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/01/1996US5561132 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
10/01/1996CA1338625C Tricyclic compounds
09/1996
09/26/1996WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
09/26/1996WO1996029407A2 Cellubrevin homologs
09/26/1996WO1996029344A1 Insulin derivatives
09/26/1996WO1996029339A1 Fucopeptides
09/26/1996WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/26/1996WO1996029304A1 Nonpeptides as tachykinin antagonists
09/26/1996WO1996029069A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis
09/26/1996WO1996029065A2 Aminotetralin derivative for the therapy of cardiovascular diseases
09/26/1996WO1996024373A3 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
09/26/1996WO1996024372A3 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996CA2216147A1 Cellubrevin homologs
09/26/1996CA2215731A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis
09/26/1996CA2215694A1 Insulin derivatives
09/26/1996CA2215671A1 Aminotetralin derivative for the therapy of cardiovascular diseases
09/26/1996CA2214107A1 Fucopeptides
09/26/1996CA2211191A1 Nonpeptides as tachykinin antagonists
09/26/1996CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/25/1996EP0733642A1 Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions
09/25/1996EP0733626A1 N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists
09/25/1996EP0733372A2 Pharmaceutical base for the formulation of nanosuspensions
09/25/1996EP0733358A2 Nanosuspensions for intravenous application
09/25/1996EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0733061A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents
09/25/1996EP0733052A1 Bicyclene derivatives, their production and use
09/25/1996EP0733051A1 Bicyclic heterocycles as neurokinin a antagonists
09/25/1996EP0733048A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
09/25/1996EP0733046A1 Novel benzoyl guanidines, their production and their use in medicaments
09/25/1996EP0732942A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
09/25/1996EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
09/25/1996EP0732940A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
09/25/1996EP0732930A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
09/25/1996EP0732929A1 Therapeutic use of cis-element decoys in vivo
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996CN1131949A Condensed indole derivatives as 5-HT4-receptor antagonists
09/25/1996CN1131907A Skin patches and methods for providing testosterone
09/25/1996CN1131666A Tricyclic pyrazole derivatives
09/25/1996CN1131545A "Zhuoli Guanxinkang" capsule for curing coronary heart disease
09/25/1996CN1131539A Treatment of disease and conditions associated with macrophage infiltration
09/25/1996CN1131538A Pharmaceutical composition for oral administration of flavonoids
09/25/1996CN1032856C Process for the preparation of novel ccylals of imidazole-5-carboxylic acid derivatives
09/24/1996US5559232 Anticoagulants
1 ... 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 ... 1595